Literature DB >> 12528097

The benefits of early treatment in rheumatoid arthritis: confounding by indication, and the issue of timing.

Robert B M Landewé.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12528097     DOI： 10.1002/art.10732

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  23 in total

1.  MRI of the wrist in early rheumatoid arthritis.

Authors:  C G Peterfy
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

2.  MORPHOMETRY FOR EARLY MONITORING OF TREATMENT RESPONSE IN RHEUMATOID ARTHRITIS.

Authors:  Anand A Joshi; Richard M Leahy; Ramsey D Badawi; Abhijit J Chaudhari
Journal:  Proc IEEE Int Symp Biomed Imaging       Date:  2013

Review 3.  Can Rheumatologists Predict Eventual Need for Orthopaedic Intervention in Patients with Rheumatoid Arthritis? Results of a Systematic Review and Analysis of Two UK Inception Cohorts.

Authors:  Elena Nikiphorou; Lewis Carpenter; Sam Norton; Stephen Morris; Alex MacGregor; Josh Dixey; Peter Williams; Patrick Kiely; David Andrew Walsh; Adam Young
Journal:  Curr Rheumatol Rep       Date:  2017-03       Impact factor: 4.592

4.  Examining radiographic outcomes over time.

Authors:  Grace S Park; Weng Kee Wong; Dinesh Khanna; Richard H Gold; Harold E Paulus
Journal:  Rheumatol Int       Date:  2013-10-29       Impact factor: 2.631

Review 5.  Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis.

Authors:  Rohit Aggarwal; Katherine Liao; Raj Nair; Sarah Ringold; Karen H Costenbader
Journal:  Arthritis Rheum       Date:  2009-11-15

6.  Production of functional recombinant cyclic citrullinated peptide monoclonal antibody in transgenic rice cell suspension culture.

Authors:  Do Van Giap; Jae-Wan Jung; Nan-Sun Kim
Journal:  Transgenic Res       Date:  2019-02-11       Impact factor: 2.788

7.  Is rheumatoid factor still a superior test for the diagnosis of rheumatoid arthritis?

Authors:  Usha Singh; Anjali Vishwanath; Pramod K Verma; Nand K Singh; Ram C Shukla; Sangeeta Singh; Suman Singh; Gyanendra K Sonkar
Journal:  Rheumatol Int       Date:  2010-01-08       Impact factor: 2.631

8.  Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis.

Authors:  Eriko Kudo-Tanaka; Shiro Ohshima; Masaru Ishii; Toru Mima; Masato Matsushita; Naoto Azuma; Yoshinori Harada; Yoshinori Katada; Hitomi Ikeue; Mitsuko Umeshita-Sasai; Kunio Miyatake; Yukihiko Saeki
Journal:  Clin Rheumatol       Date:  2007-02-08       Impact factor: 2.980

Review 9.  Anti-citrullinated protein antibodies: role in pathogenesis of RA and potential as a diagnostic tool.

Authors:  Sadaf Moeez; Peter John; Attya Bhatti
Journal:  Rheumatol Int       Date:  2013-02-01       Impact factor: 2.631

10.  Early treatment with, and time receiving, first disease-modifying antirheumatic drug predicts long-term function in patients with inflammatory polyarthritis.

Authors:  Tracey M Farragher; Mark Lunt; Bo Fu; Diane Bunn; Deborah P M Symmons
Journal:  Ann Rheum Dis       Date:  2009-10-26       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.